Literature DB >> 25281316

Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome.

Moran Rubinstein1, Ruth E Westenbroek1, Frank H Yu1, Christina J Jones1, Todd Scheuer1, William A Catterall2.   

Abstract

Dominant loss-of-function mutations in voltage-gated sodium channel NaV1.1 cause Dravet Syndrome, an intractable childhood-onset epilepsy. NaV1.1(+/-) Dravet Syndrome mice in C57BL/6 genetic background exhibit severe seizures, cognitive and social impairments, and premature death. Here we show that Dravet Syndrome mice in pure 129/SvJ genetic background have many fewer seizures and much less premature death than in pure C57BL/6 background. These mice also have a higher threshold for thermally induced seizures, fewer myoclonic seizures, and no cognitive impairment, similar to patients with Genetic Epilepsy with Febrile Seizures Plus. Consistent with this mild phenotype, mutation of NaV1.1 channels has much less physiological effect on neuronal excitability in 129/SvJ mice. In hippocampal slices, the excitability of CA1 Stratum Oriens interneurons is selectively impaired, while the excitability of CA1 pyramidal cells is unaffected. NaV1.1 haploinsufficiency results in increased rheobase and threshold for action potential firing and impaired ability to sustain high-frequency firing. Moreover, deletion of NaV1.1 markedly reduces the amplification and integration of synaptic events, further contributing to reduced excitability of interneurons. Excitability is less impaired in inhibitory neurons of Dravet Syndrome mice in 129/SvJ genetic background. Because specific deletion of NaV1.1 in forebrain GABAergic interneuons is sufficient to cause the symptoms of Dravet Syndrome in mice, our results support the conclusion that the milder phenotype in 129/SvJ mice is caused by lesser impairment of sodium channel function and electrical excitability in their forebrain interneurons. This mild impairment of excitability of interneurons leads to a milder disease phenotype in 129/SvJ mice, similar to Genetic Epilepsy with Febrile Seizures Plus in humans.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Action potential threshold; Dravet Syndrome; Epilepsy; Excitatory post synaptic potential amplification; Interneuron; Na(V)1.1; Sodium channels

Mesh:

Substances:

Year:  2014        PMID: 25281316      PMCID: PMC4254180          DOI: 10.1016/j.nbd.2014.09.017

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  66 in total

1.  Global structure, robustness, and modulation of neuronal models.

Authors:  M S Goldman; J Golowasch; E Marder; L F Abbott
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

2.  De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy.

Authors:  L Claes; J Del-Favero; B Ceulemans; L Lagae; C Van Broeckhoven; P De Jonghe
Journal:  Am J Hum Genet       Date:  2001-05-15       Impact factor: 11.025

Review 3.  Stratum oriens horizontal interneurone diversity and hippocampal network dynamics.

Authors:  Gianmaria Maccaferri
Journal:  J Physiol       Date:  2004-10-21       Impact factor: 5.182

4.  Robustness of burst firing in dissociated purkinje neurons with acute or long-term reductions in sodium conductance.

Authors:  Andrew M Swensen; Bruce P Bean
Journal:  J Neurosci       Date:  2005-04-06       Impact factor: 6.167

5.  SCN1A (2528delG) novel truncating mutation with benign outcome of severe myoclonic epilepsy of infancy.

Authors:  S Buoni; A Orrico; L Galli; R Zannolli; L Burroni; J Hayek; A Fois; V Sorrentino
Journal:  Neurology       Date:  2006-02-28       Impact factor: 9.910

6.  Contrasting effects of the persistent Na+ current on neuronal excitability and spike timing.

Authors:  Koen Vervaeke; Hua Hu; Lyle J Graham; Johan F Storm
Journal:  Neuron       Date:  2006-01-19       Impact factor: 17.173

7.  Facilitating pyramid to horizontal oriens-alveus interneurone inputs: dual intracellular recordings in slices of rat hippocampus.

Authors:  A B Ali; A M Thomson
Journal:  J Physiol       Date:  1998-02-15       Impact factor: 5.182

8.  Synaptic communication among hippocampal interneurons: properties of spontaneous IPSCs in morphologically identified cells.

Authors:  N Hájos; I Mody
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

9.  The hyperpolarization-activated current (Ih) and its contribution to pacemaker activity in rat CA1 hippocampal stratum oriens-alveus interneurones.

Authors:  G Maccaferri; C J McBain
Journal:  J Physiol       Date:  1996-11-15       Impact factor: 5.182

10.  Resurgent sodium current and action potential formation in dissociated cerebellar Purkinje neurons.

Authors:  I M Raman; B P Bean
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

View more
  36 in total

Review 1.  Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders.

Authors:  Sacha B Nelson; Vera Valakh
Journal:  Neuron       Date:  2015-08-19       Impact factor: 17.173

2.  Electrophysiological Alterations of Pyramidal Cells and Interneurons of the CA1 Region of the Hippocampus in a Novel Mouse Model of Dravet Syndrome.

Authors:  David A Dyment; Sarah C Schock; Kristen Deloughery; Minh Hieu Tran; Kerstin Ure; Lauryl M J Nutter; Amie Creighton; Julie Yuan; Umberto Banderali; Tanya Comas; Ewa Baumann; Anna Jezierski; Kym M Boycott; Alex E Mackenzie; Marzia Martina
Journal:  Genetics       Date:  2020-06-17       Impact factor: 4.562

3.  Ablation of the cardiac ryanodine receptor phospho-site Ser2808 does not alter the adrenergic response or the progression to heart failure in mice. Elimination of the genetic background as critical variable.

Authors:  Francisco J Alvarado; Xi Chen; Héctor H Valdivia
Journal:  J Mol Cell Cardiol       Date:  2017-01-06       Impact factor: 5.000

4.  Differential protection of black-seed oil on econucleotidase, cholinesterases and aminergic catabolizing enzyme in haloperidol-induced neuronal damage of male rats.

Authors:  Jacob K Akintunde; C Abigail Irechukwu
Journal:  Ther Adv Drug Saf       Date:  2016-07-22

5.  Potentiating α2 subunit containing perisomatic GABAA receptors protects against seizures in a mouse model of Dravet syndrome.

Authors:  Toshihiro Nomura; Nicole A Hawkins; Jennifer A Kearney; Alfred L George; Anis Contractor
Journal:  J Physiol       Date:  2019-05-20       Impact factor: 5.182

6.  Hippocampal deletion of NaV1.1 channels in mice causes thermal seizures and cognitive deficit characteristic of Dravet Syndrome.

Authors:  Rachael E Stein; Joshua S Kaplan; Jin Li; William A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-25       Impact factor: 11.205

7.  Impaired θ-γ Coupling Indicates Inhibitory Dysfunction and Seizure Risk in a Dravet Syndrome Mouse Model.

Authors:  Nico A Jansen; Carlos Perez; Maarten Schenke; Anouk W van Beurden; Anisa Dehghani; Rob A Voskuyl; Roland D Thijs; Ghanim Ullah; Arn M J M van den Maagdenberg; Else A Tolner
Journal:  J Neurosci       Date:  2020-11-24       Impact factor: 6.167

8.  Dravet Syndrome: A Sodium Channel Interneuronopathy.

Authors:  William A Catterall
Journal:  Curr Opin Physiol       Date:  2017-12-23

9.  Early-life febrile seizures worsen adult phenotypes in Scn1a mutants.

Authors:  Stacey B B Dutton; Karoni Dutt; Ligia A Papale; Sandra Helmers; Alan L Goldin; Andrew Escayg
Journal:  Exp Neurol       Date:  2017-04-01       Impact factor: 5.330

Review 10.  Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome.

Authors:  An-Sofie Schoonjans; Lieven Lagae; Berten Ceulemans
Journal:  Ther Adv Neurol Disord       Date:  2015-11       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.